Latest filing published 06 Jan 2025 for Pacira BioSciences, Inc., €3,748.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Daryl Gaugler: trading record in brief
Daryl Gaugler (senior executive) discloses dealings in Pacira BioSciences, Inc. to SEC (Form 4). Over a trading history stretching from 6 June 2022 to 31 December 2024, the count stands at 17 filings.
No open-market purchase appears, only 8 sales worth €306k. Other entries cover 8 share grants and 1 option exercise.
On 6 January 2025 came the latest disclosure, a share grant for €3,748 in Pacira BioSciences, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Daryl Gaugler
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 243.537 shares@ US$16.0141.3% of flowCommon StockSEC:0001396814-25-000006:0
- 500 shares@ US$19.763.4% of flowCommon StockSEC:0001396814-24-000143:0
- 500 shares@ US$12.862.1% of flowCommon StockSEC:0001396814-24-000122:0
- 160.368 shares@ US$24.3191.3% of flowCommon StockSEC:0001396814-24-000089:0
- 54,300 shares0Common StockSEC:0001396814-24-000078:0
- 2,754 shares@ US$30.8927.9% of flowCommon StockSEC:0001396814-24-000052:0
- 33,700 shares0Common StockSEC:0001396814-24-000017:0
- 10,000 shares0Common StockSEC:0001209191-23-038022:0
- 1,000 shares@ US$38.7412.9% of flowCommon StockSEC:0001209191-23-035256:0
- 2,500 shares@ US$34.0028.4% of flowCommon StockSEC:0001209191-23-033985:0
- 1,106 shares@ US$61.37422.7% of flowCommon StockSEC:0001209191-22-035221:0
11 of 11 declarations
